Atividade leishmanicida e citotoxicidade de constituintes químicos de duas espécies de Annonaceae cultivadas no nordeste do Brasil by VILA-NOVA, Nadja Soares et al.
567
Revista da Sociedade Brasileira de Medicina Tropical 44(5):567-571, set-out, 2011
INTRODUCTION
Article/Artigo
1. Programa de Pós-Graduação em Ciências Veterinárias, Faculdade de Medicina Veterinária, Universidade 
Estadual do Ceará, Fortaleza, CE. 2. Curso de Química, Centro de Ciências e Tecnologia, Universidade 
Estadual do Ceará, Fortaleza, CE. 3. Departamento de Química Orgânica e Inorgânica, Centro de 
Ciências, Universidade Federal do Ceará, Fortaleza, CE. 4. Instituto de Medicina Tropical, Laboratório 
de Protozoologia, Universidade de São Paulo, São Paulo, SP. 
Address to: Dra. Selene Maia de Morais. Rua Ana Bilhar 601/400, Meireles, 60160-110 Fortaleza, CE, Brasil.
Phone: 55 85 3242-6811; 55 85 3101-9933
e-mail: selene.maia@pq.cnpq.br
Received in 15/03/2011
Accepted in 07/06/2011
Leishmanicidal activity and cytotoxicity of compounds from two 
Annonacea species cultivated in Northeastern Brazil
Atividade leishmanicida e citotoxicidade de constituintes químicos de duas espécies de 
Annonaceae cultivadas no nordeste do Brasil
Nadja Soares Vila-Nova1, Selen Maia de Morais1,2, Maria José Cajazeiras Falcão2, Lyeghyna Karla Andrade Machado2, 
Cláudia Maria Leal Beviláqua1, Igor Rafael Sousa Costa2, Nilce Viana Gramosa Pompeu de Sousa Brasil3 
and Heitor Franco de Andrade Júnior4
ABSTRACT
Introduction: Visceral leishmaniasis is endemic in 88 countries, with a total of 12 million 
people infected and 350 million at risk. In the search for new leishmanicidal agents, alkaloids and 
acetogenins isolated from leaves of Annona squamosa and seeds of Annona muricata were tested 
against promastigote and amastigote forms of Leishmania chagasi. Methods: Methanol-water 
(80:20) extracts of A. squamosa leaves and A. muricata seeds were extracted with 10% phosphoric 
acid and organic solvents to obtain the alkaloid and acetogenin-rich extracts. These extracts 
were chromatographed on a silica gel column and eluted with a mixture of several solvents in 
crescent order of polarity. The compounds were identified by spectroscopic analysis. The isolated 
compounds were tested against Leishmania chagasi, which is responsible for American visceral 
leishmaniasis, using the MTT test assay. The cytotoxicity assay was evaluated for all isolated 
compounds, and for this assay, RAW 264.7 cells were used. Results: O-methylarmepavine, a 
benzylisoquinolinic alkaloid, and a C37 trihydroxy adjacent bistetrahydrofuran acetogenin were 
isolated from A. squamosa, while two acetogenins, annonacinone and corossolone, were isolated 
from A. muricata. Against promastigotes, the alkaloid showed an IC50 of 23.3 µg/mL, and the 
acetogenins showed an IC50 ranging from 25.9 to 37.6 µg/mL; in the amastigote assay, the IC50 
values ranged from 13.5 to 28.7 µg/mL. The cytotoxicity assay showed results ranging from 43.5 
to 79.9 µg/mL. Conclusions: These results characterize A. squamosa and A. muricata as potential 
sources of leishmanicidal agents. Plants from Annonaceae are rich sources of natural compounds 
and an important tool in the search for new leishmanicidal therapies.
Keywords: Leishmaniasis. Benzylisoquinolinic alkaloids. Acetogenins. Annona squamosa. 
Annona muricata.
RESUMO
Introdução: A leishmaniose visceral é uma enfermidade endêmica em 88 países, com um total 
de 12 milhões de pessoas infectadas e 350 milhões em risco. Na procura de novos agentes com 
ação leishmanicida, alcalóides e acetogeninas isoladas de Annona squamosa e Annona muricata, 
foram testados contra as formas promastigotas e amastigotas de Leishmania chagasi. Métodos: 
Foram preparados extratos com metanol: água (80: 20) das folhas de A. squamosa e sementes 
de A. muricata que foram extraídos com solução de ácido fosfórico 10% e solventes orgânicos, 
para obter extratos ricos em alcalóides e acetogeninas. Estes extratos foram cromatografados em 
coluna de sílica gel sendo eluídos com solventes de diferentes polaridades para o isolamento dos 
constituintes, e feita a determinação estrutural por análise espectroscópica. Os constituintes isolados 
foram testados contra Leishmania chagasi, responsável pela leishmaniose visceral, utilizando o teste 
MTT. Testes de toxicidade foram realizados em todos os compostos isolados, sendo utilizadas 
células RAW 264.7. Resultados: Um alcalóide benzilisoquinolínico, O-metilarmepavina, e uma 
C37-triidróxi-acetogenina com anel bistetrahidrofurânico adjacente foram isolados de A. squamosa 
e duas acetogeninas annonacinona e corossolona da A. muricata. O alcalóide mostrou um índice 
de inibição médio (IC50) de 23,3µg/mL e as acetogeninas apresentaram IC50 variando entre 25,9 a 
37,6µg/mL contra promastigotas, e no ensaio de amastigotas, o IC50 valores variaram entre 13,5 a 28,7 
µg/mL. A toxicidade mostrou resultados que variaram entre 43,5 a 79,9µg/mL. Conclusões: Estes 
resultados caracterizam A. squamosa e A. muricata como fontes potenciais de agentes leishmanicidas. 
Palavras-chaves: Leishmaniose. Alcaloide benzilisoquinolinico. Acetogenina. Annona squamosa. 
Annona muricata.
Leishmaniasis is a tropical zoonotic disease 
caused by at least 17 protozoa species of the 
Leishmania genus1. The forms of the disease are 
related to the type of parasite and differ in geographic 
distribution, the host and vector involved, incidence 
rate, and mortality2. Visceral leishmaniasis is 
endemic in 88 countries, with a prevalence of 12 
million people, causing 500,000 cases a year, besides 
those cases of asymptomatic individuals that are not 
diagnosed3, 4.
The chemotherapy of leishmaniasis is based 
on the use of toxic heavy metal-based compounds, 
particularly pentavalent antimonials. However, these 
compounds must be administered over prolonged 
periods and are often associated with serious side 
effects, including cardiotoxicity, pancreatitis, and 
musculoskeletal affections, when used at therapeutic 
doses. Other treatments for leishmaniasis, such as 
amphotericin B and pentamidine, are associated with 
multiple adverse side effects, such as bone marrow 
suppression, renal toxicity, and glucose metabolism 
disturbances1, 5, 6.
Plants that are traditionally used for treatment 
of several diseases caused by protozoa are attracting 
attention in tests against different Leishmania 
species. Leishmanicidal acetogenins and alkaloids 
from the Annonacea species have demonstrated 
the great potential of this plant family as a source of 
leishmanicidal agents5, 7.
In Northeastern Brazil, two species of Annonacea 
are largely cultivated due to their characteristics of 
edibility and high amount of waste material for the 
pulp industry and other markets. To make use of this 
discharged material, this study aimed to evaluate, 
in vitro, the effectiveness of constituents from 
A. squamosa leaves and A. muricata seeds against the 
promastigote and amastigote forms of Leishmania 
(L.) chagasi.
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Plant materials
Leaves of A. squamosa and A. muricata were collected from the 
Ceará State University campus in Fortaleza, State of Ceará, Brazil. 
The aerial parts of the plants were deposited in the Prisco Bezerra 
Herbarium under reference numbers 43,604 and 43,951, respectively.
Isolation of compounds and spectroscopic identification
The plant materials (2kg) were powdered, air-dried, immersed in 
a methanol-H2O solution (80:20, 1.5 l), and left for 7 days at room 
temperature. After this period, the solvent was eliminated using a 
rotative evaporator, leaving the crude extract (CE). Part of the CE 
was dissolved with 10% phosphoric acid and then the aqueous acid 
mixture was washed with dichloromethane. The organic phase was 
evaporated to dryness to obtain an acetogenin-rich extract (ACE, 
82 g). The ACE was submitted to silica gel column chromatography, 
being eluted with hexane, dichloromethane, ethyl acetate, and 
methanol in mixtures of increasing polarity. The fractions were 
collected and compared in thin layer chromatographic (TLC) plates 
sprayed with Kedde´s reagent to reveal the acetogenins. Ammonium 
hydroxide was added to the aqueous acid solution until pH 9, 
after which the solution was partitioned with dichloromethane. 
Dragendorff ’s reagent was used until a negative reaction was 
seen. The dichloromethane phase was dried over sodium sulfate 
and concentrated under reduced pressure until complete dryness 
to obtain the total alkaloid extract (AE, 0.58g). This extract was 
submitted to the same silica gel column chromatographic treatment as 
above, using Dragendorff´s reagent for spraying the TLC plates. The 
chemical structures of the isolated compounds were determined by 
spectroscopic analysis of infrared spectra, recorded on a PerkinElmer 
100 FT-IR spectrophotometer; the values were expressed in cm-1, and 
the nuclear magnetic resonance spectra were recorded on a Bruker 
Avance DRX-500 spectrometer in CDCl3.
Parasites
Leishmania (L.) chagasi (M6445 strain) promastigotes were 
cultured in M199 medium supplemented with 10% fetal bovine 
serum and 5% human male urine at 24°C. RAW 264.7 murine 
macrophages (ATCC TIB-71) were maintained in RPMI-1640 
medium supplemented with 10% fetal bovine serum at 37°C in a 5% 
CO2 humidified incubator and seeded for 24 h at 4.10
5 cells per well 
in 96-well plates before infection with L. chagasi promastigotes. The 
amastigotes were obtained from RAW 264.7 murine macrophage 
cells infected with promastigote at a ratio of 1:10 (macrophage/
promastigote), kept in a 5% CO2 humidified incubator for 72 h at 37ºC, 
and then analyzed under a light microscope to confirm infection.
Leishmanicidal activity
Test against promastigotes: To determine the 50% effective 
concentration (EC50 value) of the compounds against L. chagasi 
promastigotes, all compounds were dissolved previously in ethanol 
at a concentration of 0.2% and diluted with M199 medium in 96-
well microplates. The assay was performed at concentrations of 
100, 50, 25, 12.5, and 6.25µg/mL, and controls with ethanol and 
without drugs were performed. Each concentration was tested nine 
times. Promastigotes were counted in a Neubauer haemocytometer 
and seeded at 1x106 cells per well for a final volume of 150µl. The 
plates were incubated at 24°C for 24h, and the viability of the 
promastigotes was assessed by morphological observation under a 
light microscope. Diphenyltetrazolium (MTT) assay was performed; 
initially, MTT (5mg/mL) was dissolved in PBS and sterilized through 
0.22-µm membranes, and then 20µl/well was added to a 96-well 
plate and left at 37°C for 4 h. Promastigotes were incubated without 
compounds and used as viability control. Formazan extraction was 
performed using 10% SDS (100 mL/well) at 24°C for 18h, and the 
optical density (OD) at 570 nm was determined in a Multiskan MS 
spectrophotometer (UniScience). Pentamidine (Ítaca Laboratórios 
Ltda, Rio de Janeiro, Brazil) was used as standard drug (50mg/mL).
Test against amastigotes: To determine the EC50 value of the 
compounds against L. chagasi amastigotes, all compounds were 
dissolved in 0.2% ethanol at concentrations of 100, 50, 25, 12.5, 
and 6.25µg/mL and added to microplates containing a confluent 
layer of cells with amastigotes for 48h at 37°C in a 5% CO2 
humified incubator. Glucantime was used as standard drug, and 
macrophages incubated without drugs were used as control. For 
the in vitro assay, an adapted methodology from Piazza et al.8 was 
used. The RAW 264.7 cells were incubated with 0.01% saponin 
in PBSA containing 1% bovine serum albumin for 30 min. After 
blocking the wells for 30 min with 5% defatted milk (Nestlé) in 
PBSA, the cells were incubated at 37°C for 1h with serum from a 
rabbit immunized with saline extract of L. chagasi promastigotes, 
collected 30 days after the infection. The serum employed was 
diluted at 1:500 and pre-absorbed with 10% fetal calf serum 
(FCS) at 22°C for 1 h. After washing the wells three times with 
0.05% Tween 20 in PBSA, peroxidase-conjugated goat anti-rabbit 
IgG (Sigma Chemical Co.), diluted 1:5,000 in 5% defatted milk 
was added, and the mixture was left at 37°C for lh. The wells 
were washed three times, after which o-phenylenediamine 
(0.4mg/mL) and 0.05% H202 were added. The solution was then 
transferred to ELISA microplates. The reaction was stopped by 
adding 1 M HC1, and the plates read at 492nm in a Titertek 
Multiskan ELISA reader.
Cytotoxicity assay
For the cytotoxicity assay, an adapted methodology from 
Tempone (2005) was used. RAW 264.7 murine macrophage cells 
were seeded at 4x104 cells per well in 96-well microplates and 
incubated at 37°C for 48h in the presence of the compounds, 
dissolved previously in ethanol at a concentration of 0.2% and diluted 
with M199 medium to the highest concentration of 120µg/mL. The 
microplates were incubated for 48h at 37°C in a 5% CO2 humidified 
incubator. Control cells were incubated in the presence of DMSO, 
without drugs, Glucantime, and pentamidine (standard drugs). The 
viability of the macrophages was determined with the MTT assay, as 
described above, and was confirmed by comparing the morphology 
of the control group via light microscopy.
Statistical analysis
The EC50 values at 95% confidence interval (CI) were 
calculated using a nonlinear regression curve. One-way ANOVA 
and comparative analysis between treatments were performed by 
Tukey’s parametric test using the number of living promastigotes 
and amastigotes determined indirectly by the optical density (OD, 
570nm), representing the percentage of survival and/or murine 
macrophage cells after normalization using the statistical software 
GraphPad Prism 4.0.
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RESULTS
TABLE 1 - 1H (CDCl3, 500 MHz) and 13C-NMR (CDCl3, 125 MHz) chemical 
shifts of compounds III and IV isolated from Annona muricata.
 III III IV IV
Compound (C) 1H 13C 1H 13C
1 - 174.84 - 174.08
2 - 131.31 - 134.45
3a 2.39 - - -
3b 2.50 33.64 2.26 25.31
4 3.83 70.01 1.52-1.58 27.55
5 1.25-1.29 37.30 1.31 28.97-29.92
6-7 1.25-1.29 29.20-29.92 1.31 28.97-29.92
8 1.55 23.99 1.52-1.58 23.97
9 2.38 42.79 2.37-2.43 42.99
10 - 211.60 - 211.55
11 2.38 42.88 2.37-2.43 42.91
12 1.55 23.84 1.52-1.58 25.35
13 1.25-1.29 25.42 1.31 25.47
14 1.38 33.64 1.38 33.45
15 3.49 74.32 3.40 74.15
16 3.80 82.75 3.79 82.79
17-18 1.64-1.98 28.96 1.68-1.98 29.01
19 3.80 82.89 3.79 82.89
20 3.40 74.02 3.40 74.00
21 1.39 33.59 1.38 33.70
22 1.25-1.29 25.78 1.31 25.80
23-29 1.25-1.29 29.20-29.92 1.31 28.97-29.92
30 1.25-1.29 32.11 1.31 32.12
31 1.25-1.29 22.88 1.31 22.89
32 0.87 14.32 0.89 14.32
33 7.18 152.12 6.99 149.15
34 5.05 78.21 4.99 77.62
35 1.39 19.29 1.38 19.42
The silica gel column chromatography of the alkaloid extract 
of A. squamosa leaves led to the isolation of O-methylarmepavine 
(I), a benzylisoquinolinic alkaloid; and from the methanol extract 
free from alkaloids,  a C37 trihydroxy adjacent bistetrahydrofuran 
acetogenin (II) was isolated (Figure 1). This acetogenin was shown 
to be identical, when compared by thin layer chromatography (TLC) 
and spectroscopic data, with the acetogenin previously identified 
in A. squamosa seeds, which showed anthelmintic activity against 
Haemonchus contortus, the main nematode in small ruminants in 
Northeastern Brazil9. The complete assignment of carbons and 
hydrogens for the structure of O-methylarmepavine was performed 
using one- and two-dimensional NMR spectral analysis and by 
comparison with data from previous studies10, 11.
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FIGURE 1 - Chemical structures of the leishmanicidal compounds 
O-methylarmepavine (I) and C37 trihydroxy adjacent bistetrahydrofuran 
acetogenin (II) from A. squamosa and Corossolone (III) and Annonacinone 
(IV) from A. muricata.
Compound I was isolated as a brown solid: m.p.: 49.9-50.7oC; 
UV (λmax, MeOH, nm): 225 (log ε 3.19); IR (KBr) δmax 2.935, 
1.612, 1.514, 1.460, 1.250, 1.118, 1.068, 1.033, 833 cm-1; 1H NMR 
(CDCl3, 500 MHz) 5.83 (H1), 6.58 (H4, s), 2.2-2.4 (H5, m), 3.10 
(H6a, d, 7.0), 3.39 (H6b, t, 7.15), 4.32 (H7a, m), 2.78 (H8, t, 6.4), 
7.0 (H9/H13, d, 8.4), 6.79 (H10/H12, d, 8.4), 3.48 (OCH3), 3.82 
(OCH3), 3.77 (OCH3), 2.64 (N- CH3) and 
13C NMR 65.05 (C1), 
149.45 (C2), 147.49 (C3), 111.24 (C4), 22.02 (C5), 44.94 (C6), 
65.45 (C7a), 40.25 (C8), 114.27 (C9/C13), 131.17 (C10/C12), 
159.21 (C11), 122 (C14), 121 (C15), 122 (C16), 55.72 (OCH3), 
56.06 (OCH3), 55.86 (OCH3), 40.44 (N- CH3).
Compound II was isolated as a viscous oil: UV (λmax, MeOH, nm): 
281 (log ε 3.41); IR (KBr) λmax 3.418, 2.927, 2.855, 1.748, 1.652, 
1.463, 1.319, 1.118, 1.068, 1.028, 953, 877, 756, 666 cm-1; 1H NMR 
(CDCl3, 500 MHz) 2.29 (H3, t 7.8), 1.56 (H4, m), 3.62 (H5, m), 
1.55 (H6, m), 1.28 (H7, m), 1.28 (H8-12, m), 1.28 (C13, m), 1.56 
(H14, m), 3.34 (H15, m), 3.84 (H16, m), 1.98 (H17a, m), 1.65 (H17b, 
m), 1.98 (H18a, m), 1.65 (H18b, m), 3.94 (H19, m), 3.94 (H20, m), 
1.98 (H21a, m), 1.65 (H21b, m), 1.98 (H22a, m), 1.65 (H22b, m), 
3.84 (H23, m), 3.43 (H24, m), 1.56 (H25, m), 1.28 (H26, m), 1.28 
(H27,31, m), 1.28 (H32, m), 1.28 (H33, m), 0.90 (H34, t 7.0), 6.99 
(H35, s), 5.02 (H36, m), 1.43 (H37, d 6.7); and 13C NMR (CDCl3, 
125 MHz) 173.8 (C1), 134.2 (C2), 25.6 (C3), 37.1 (C4), 71.7 (C5), 
37.3 (C6), 24.8 (C7), 28.9-29.6 (C8-12), 25.1 (C13), 33.0 (C14), 
74.1 (C15), 83.2* (C16), 27.3 (C17), 28.4 (C18), 82.5* (C19), 82.1* 
(C20), 28.4 (C21), 27.3 (C22), 82.7* (C23), 71.4 (C24), 32.3 (C25), 
25.6 (C26), 28.9-29.6 (27-31), 31.8 (C32), 22.5 (C33), 14.0 (C34), 
148.9 (C35), 77.4 (C36), 19.1 (C37). *Values are exchangeable.
The 1H and 13C-NMR spectral data of compounds III and IV (Table 1) 
indicate the characteristics of y-lactone mono-tetrahydrofurans with 
a keto group (peak at δ211.60 for compound III and at δ211.55 for 
compound IV in 13C-NMR), differing in the number of hydroxyl groups. 
Compound III, which is less polar, shows two hydroxyls located at C15, 
δ74.15 and at C20, δ74.00 in the 13C-NMR spectra; these data were 
compared with those for corossolone, which was previously isolated 
by Cortes et al.12 Compound IV, with three hydroxyls linked to C15, 
δ74.32; C20, δ74.01; and C4, δ70.01 was compared with the structure of 
annonacinone13. The structures of corossolone (III) and annonacinone 
(IV) are shown in Figure 1.
In the search for new drugs with leishmanicidal activity, 
A. squamosa and A. muricata constituents were tested against 
L. chagasi promastigotes. In this assay, pentamidine was used 
as standard drug and showed an EC50 value of 1.63µg/mL; the 
acetogenin from A. squamosa showed an IC50 value of 26.4µg/mL, and 
the alkaloid O-methylarmepavine showed an IC50 value of 23.3µg/mL. 
The assay using annonacinone and corossolone isolated from A. muricata 
showed IC50 values of 37.6 and 25.9µg/mL, respectively (Table 2).
In the amastigote assay, compounds I and II showed IC50 values 
of 25.3 and 25.4µg/mL, respectively, and compounds III and IV 
showed IC50 values of 13.5 and 28.7µg/mL, respectively, which were 
statistically similar. The standard drug used, pentamidine, showed an 
IC50 value of 1.60 µg/mL (Table 2).
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TABLE 2 - Effect of Annona squamosa and Annona muricata compounds and 
standards on extra-extracellular promastigote and intra-intracellular amastigote 
forms of Leishmania chagasi and their cytotoxicity in mammalian cells.
 *EC50 *EC50 EC50 y
 promastigotes amastigotes cytotoxicit
Compounds (µg/mL) (95% CI) (µg/mL) (95% CI) (µg/mL) (95% CI)
Alkaloid (I) 23.3a (12.3-38.7) 25.4a (6.1-105.9) 79.7a (9.3-61.8)
Acetogenin (II) 26.4a (22.6-98-5) 25.3a (22.7-28.1) 43.5b (23-129.1)
Acetogenin (III) 25.9a (7.6-88.2) 28.7a (6.2-67.4) 54b (28.3-119.7)
Acetogenin (IV) 37.6a (25.8-54.80) 13.5b (2.1-53.6) 59.5b(9.4-88.4)
Pentamidine 1.6b (0.06-63.4) nd 17.9c(2.4-25.8)
Glucantime nd 17.4b (0.01-169.3) >100d
The different letters in the columns show the statistical difference between the EC50 
values (p<0.05) by Tukey´s test. EC50: 50% effective concentration; 95% CI: 95% 
confidence interval; nd: not determined. 
*Values indicate the effective concentration of a compound in µg/mL necessary to 
achieve 50% growth inhibition (EC50).
The cytotoxicity of the compounds was determined in RAW 
264.7 macrophages after 48-h incubation. The cytotoxicity of the 
alkaloid (I) and acetogenin (II) isolated from A. squamosa, and 
the acetogenins corossolone (III) and annonacinone (IV) from 
A. muricata against RAW 264.7 murine macrophage cells showed 
values ranging from 43.5 to 79.7µg/mL. The standard drug glucantime 
showed toxicity to mammalian cells greater than 100µg/mL (Table 2).
DISCUSSION
Leishmaniasis occurs globally. In particular, visceral leishmaniasis 
has a major impact in the Horn of Africa, South Asia, and Brazil, 
and cutaneous leishmaniasis in Latin America, Central Asia, and 
southwestern Asia. The species responsible for leishmaniasis in 
Latin America are divided in two taxonomic groups. The first is the 
subgenus Viannia, which mainly includes the species L. braziliensis, 
L. panamensis, and L. guyanesis, responsible for cutaneous or 
mucocutaneous lesions. The other is the Leishmania subgenus, which 
includes the species L. mexicana and L. amazonensis, responsible 
for localized or diffused skin lesions, and L. chagasi, which causes 
American visceral leishmaniasis14.
In this study, an alkaloid and three different acetogenins from two 
species of Annonacea plants, Annona squamosa and Annona muricata, 
were isolated. A. squamosa leaves contain a benzylisoquinolinic 
alkaloid, O-methylarmepavine (I), and a C37 trihydroxy adjacent 
bistetrahydrofuran acetogenin (II). From A. muricata seeds, two 
different acetogenins, corossolone (III) and annonacinone (IV), 
were isolated. These compounds were screened against Leishmania 
chagasi promastigote and amastigote forms, and their cytotoxicities 
were evaluated.
The leishmanicidal tests against L. chagasi using the alkaloid 
isolated from A. squamosa, O-methylarmepavine, revealed lower 
effectiveness when compared with the standard drug pentamidine. 
Tempone et al. tested the total alkaloid and ethanol extract from eight 
different Annonacea plants, which produce isoquinoline alkaloids, 
and showed effective results in vitro against L. chagasi. The most 
effective total alkaloid extract against promastigotes and amastigotes 
was that from Annona crassiflora.
The alkaloid O-methylarmepavine isolated from A. squamosa is 
a benzylisoquinolinic alkaloid. Isoquinoline and benzylisoquinoline 
analogues are the main leishmanicidal alkaloid types in the 
Annonacea family. Benzylisoquinolinic alkaloids are widely 
distributed in nature and have been isolated from different plants 
commonly used in traditional medicine for the treatment of 
parasitic diseases. Bisbenzylisoquinolinic alkaloids isolated from 
the stem bark of Guatteria boliviana have also been reported to 
show moderate activity when tested against promastigotes of 
L. donovani, L. amazonensis, and L. braziliensis5. Berberine, a 
quaternary isoquinolinic alkaloid, has been used in the clinical 
treatment of leishmaniasis, malaria, and amebiasis for more than 
50 years and has shown in vitro and in vivo response against many 
species of Leishmania. This alkaloid, at a concentration of 10µg/
mL, effectively eliminates L. major parasites in peritoneal mice 
macrophages15,16. Another isoquinolinic alkaloid, isoguattouregidine, 
isolated from Guatteria foliosa, caused lysis of parasitic cell 
membrane when tested against L. donovani and L. amazonensis at 
a concentration of 100µg/ml. Anonaine and liriodenine obtained 
from the roots and trunk bark of A. pinescens showed an IC50 value 
of 100µg/mL against promastigotes of L. braziliensis, L. amazonensis, 
and L. donovani17. About 20 bisbenzylisoquinoline alkaloids were 
screened for antileishmanial and antitrypanosomal activity in vitro; 
Fangchinoline (IC50 0.39μM) was found to be as active as the standard 
drug pentamidine against Leishmania donovani promastigotes. Based 
on the above results, the leishmanicidal action of isoquinoline and 
benzylisoquinoline against the promastigote forms of Leishmania 
spp ranged from 0.39 to 100µg/mL18. The mechanism of action of 
alkaloids is not completely understood, but Fournet et al.19 observed 
that bisbenzylisoquinolinic alkaloids inhibit an essential antioxidant 
enzyme in Leishmania, trypanothione reductase.
The acetogenin isolated from seeds of A. muricata, corossolone, 
showed the best activity among the three acetogenins used in this 
study. More than 160 different types of acetogenins are found in 
the Annonacea family. From the different species of Annonacea, 12 
containing mono- and bis-THF ring acetogenins were isolated and 
tested against promastigotes and amastigotes of L. donovani. The 
results of this study against promastigotes showed a range between 2.5 
and 47.3μM. Rollinistatin was the most effective against amastigotes, 
with an IC50 value of 2.5μM. Some acetogenins with one THF ring, 
such as senegalene, or two THF rings, such as squamocine, asimicine, 
and molvizarine, isolated from seeds of A. senegalensis showed activity 
against promastigotes of L. major and L. donovani at 25-100µg/mL20.
Nine acetogenins with one or two THF rings were isolated from 
the seeds of A. glauca; their activity against L. donovani, L. braziliensis, 
and L. amazonensis was evaluated. The mono-THF ring acetogenins 
annonacin A and goniothalamicin showed activity against 
promastigotes, with EC100 values of 10 and 5µg/mL, respectively
21.
In the amastigote assay using L. chagasi strains, the acetogenins 
from the two Annonacea species in the present study showed IC50 
values ranging from 13.5 to 28.7µg/mL, indicating the relevance 
of these compounds in the search for new leishmanicidal drugs. 
Regarding cytotoxicity, the alkaloid and all the acetogenins were more 
toxic to mammalian cells when compared with the standard drug.
The World Health Organization recommends pentavalent 
antimonials as first-choice drugs for leishmaniasis treatment. 
Although Glucantime® has traditionally been used to treat 
leishmaniasis, its mechanisms of action and ability to induce damage 
in DNA are still unclear. In the study of Lima et al.22, the genotoxic 
activity of this drug was evaluated in vitro using human lymphocytes, 
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